Depotplastre som administrasjonsprinsipp for legemidler
- 1 January 2009
- journal article
- abstracts
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 129 (6), 532-533
- https://doi.org/10.4045/tidsskr.09.33349
Abstract
Transdermal therapeutic systems, or transdermal patches, facilitate controlled release of active ingredients through the skin and into the systemic circulation. Drugs administered through such systems escape first pass metabolism and steady state is maintained similar to a continuous intravenous infusion for up to several days. Few pharmacologically active substances can currently be administered through transdermal patches and production is technically demanding. Research is ongoing to improve the systems and expand the indications. This article gives a brief overview over principles behind various transdermal patch types, as well as the advantages and disadvantages of transdermal therapeutic systems.Keywords
This publication has 6 references indexed in Scilit:
- Cutaneous Reactions to Transdermal Therapeutic SystemsDermatitis®, 2006
- Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attributeEuropean Journal of Pharmaceutics and Biopharmaceutics, 2006
- Dermal and Transdermal Drug Delivery Systems: Current and Future ProspectsDrug Delivery, 2006
- Penetration enhancersAdvanced Drug Delivery Reviews, 2003
- Novel mechanisms and devices to enable successful transdermal drug deliveryEuropean Journal of Pharmaceutical Sciences, 2001
- Pharmacokinetic Characterisation of Transdermal Delivery SystemsClinical Pharmacokinetics, 1994